• Paroxetine Mesylate in SUDEP Biomarker Research

  2026-08-13

  Paroxetine Mesylate offers a distinctive pharmacological perturbation for studying serotonergic, metabolic, and cardiac variables in epilepsy research. This article translates a captive baboon ECG–EEG study into practical assay-design guidance while separating established findings from exploratory drug effects.

• Canagliflozin Remodels Proximal Tubule Mitochondria

  2026-08-13

  A 2025 study shows that Canagliflozin improves mitochondrial architecture and bioenergetics in proximal tubular cells from hypertensive–diabetic mice, extending analysis beyond glucose lowering and albuminuria. The sex-dependent findings support mitochondrial remodeling as a plausible contributor to renal protection while highlighting important causal and translational limitations.

• Idoxuridine for Causal Antiviral Assays

  2026-08-12

  Use Idoxuridine as a mechanistic probe, not only as a viral-growth endpoint reagent. This workflow combines dose response, time-resolved viral DNA measurements, washout studies, and orthogonal viability controls to distinguish DNA replication disruption from nonspecific toxicity.

• Ferritin Hybrid Vaccine for Influenza and SARS-CoV-2

  2026-08-12

  The reference study develops an Escherichia coli-produced ferritin particle that co-displays influenza A M2e and SARS-CoV-2 S-protein tandem epitopes. In mice, the hybrid particle improved antigen-specific responses and generated sera with pseudovirus inhibition, M2e binding, and ADCC-associated activity, supporting ferritin as a flexible combination-vaccine platform.

• MnTBAP Chloride: From Redox Mechanism to Translation

  2026-08-11

  A translational perspective on how MnTBAP Chloride links mitochondrial superoxide scavenging with oxidative injury, inflammation, and chronic stress models—while defining the evidence, protocol considerations, and limitations that matter beyond a typical product page.

• Polymyxin B and the LPS–Immunotherapy Axis

  2026-08-11

  A translational framework for using Polymyxin B sulfate to dissect membrane disruption, LPS biology, dendritic-cell activation, and microbiome-dependent checkpoint responses without confusing experimental perturbation with therapeutic promise.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-10

  FITC-Concanavalin A (ConA) Conjugate provides a direct fluorescent method for visualizing α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It is appropriate for cell-surface carbohydrate detection, immunofluorescence staining, tissue imaging, and flow cytometry, but it should not be treated as a universal glycan stain or a probe for non-carbohydrate targets.

• JC-1 Mitochondrial Membrane Potential Assay Kit Guide

  2026-08-09

  Learn how the JC-1 Mitochondrial Membrane Potential Assay Kit can turn ΔΨm changes into a decision-grade functional readout. This guide connects ratiometric mitochondrial analysis with the redox, signaling, and immunosuppressive mechanisms highlighted in recent oncology research.

• Caspofungin: Applied Antifungal Research Workflows

  2026-08-08

  Build more informative Candida assays with Caspofungin by combining susceptibility testing, time-kill analysis, and cell-wall-focused readouts. The workflow also shows how to interpret caspofungin alongside ibrexafungerp in fluconazole-resistant Candida auris models without confusing in vitro potency with in vivo efficacy.

• Metformin Hydrochloride in Ossification Research

  2026-08-07

  Metformin Hydrochloride connects metabolic signaling with practical models of tendon-derived osteogenesis, offering a focused way to interrogate AMPK, Nr4a1, and Wnt/β-catenin biology. This workflow-oriented guide covers formulation, cell and mouse study design, assay selection, and troubleshooting for reproducible research.

• 3X (DYKDDDDK) Peptide: Precision Tagging for Advanced Protei

  2026-08-07

  The 3X (DYKDDDDK) Peptide enables highly sensitive, reproducible affinity purification and immunodetection of recombinant proteins, even under challenging conditions. Explore next-generation protocols, troubleshooting strategies, and real-world applications that leverage its unique calcium-dependent specificity and robust hydrophilicity.

• Metformin Hydrochloride (Metformin HCl): Reliable Solutions

  2026-08-06

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays using Metformin Hydrochloride (Metformin HCl, SKU B1970). It provides scenario-driven guidance on experimental design, protocol optimization, and data interpretation, emphasizing evidence-based practices and the distinct advantages of APExBIO’s reagent.

• TAK-242 (Resatorvid): Advanced TLR4 Inhibition in Research

  2026-08-06

  TAK-242 (Resatorvid) brings precision TLR4 pathway modulation to neuroinflammation and immune signaling studies, delivering nanomolar potency and workflow flexibility. Its robust inhibition of LPS-induced cytokine production empowers researchers to dissect inflammatory cascades with clarity, even in complex bench models.

• CGP 55845 Hydrochloride: Unveiling GABAB Antagonism in Synap

  2026-08-05

  This thought-leadership article explores how CGP 55845 hydrochloride, a potent and selective GABAB receptor antagonist, enables translational researchers to probe astrocyte-mediated regulation of synaptic transmission and memory formation in the dentate gyrus. By integrating the latest mechanistic insights into astrocytic GAT-3 signaling with practical assay guidance, the discussion illustrates how CGP 55845 hydrochloride empowers advanced in vitro models for unraveling neurotransmitter release modulation, bridging molecular pharmacology with cognitive neuroscience.

• Hoechst 33258: Optimizing Bis-Benzimide DNA Staining Workflo

  2026-08-05

  Hoechst 33258, a gold standard bis-benzimide DNA stain, excels in both live and fixed cell applications, enabling reliable DNA visualization and cell cycle analysis even in challenging tumor microenvironments. Explore advanced protocol strategies, troubleshooting, and the impact of recent pH-disrupting chemo-immunotherapy innovations on assay design.

8476 records 8/566 page Previous Next First page 上5页 678910 下5页 Last page